- Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction. Annibale, B., Delle Fave, G., Azzoni, C., Corleto, V., Camboni, G., D'Ambra, G., Pilato, F.P., Bordi, C. Aliment. Pharmacol. Ther. (1994)